This EPP research programme has contributed substantially to understanding the complete biology of MC1R-mediated photoprotection beyond suntan induction
Not every patient achieves the weight loss targets they are hoping for, and a meaningful proportion of patients even on maximum doses do not reach the 1520% body weight reduction that clinical guidelines increasingly use as a benchmark for meaningful metabolic benefit
Patients who combine semaglutide GLP-1 therapy with balanced nutrition, regular physical activity, and consistent medical monitoring often see more reliable progress
This is particularly pertinent given the apparent increase in GSH in BPAD and reduction in unipolar depression, suggesting that the affective state may account for these differences
However, over the next year, initiation slowed and even reversed: with first-time prescribing rates declining 31% by June 2025, reflecting an average month-over-month decrease of 0.004 percentage points